WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017069721) ANTIVIRAL PHARMACEUTICAL COMPOSITION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2017/069721    International Application No.:    PCT/UA2016/000122
Publication Date: 27.04.2017 International Filing Date: 24.10.2016
IPC:
A61K 9/00 (2006.01), A61K 31/716 (2006.01), A61K 31/731 (2006.01), A61P 31/22 (2006.01)
Applicants: TOLCHEYEV, Yuriy Zakharovych [UA/UA]; (UA).
KOZLOVSKYI, Vadym Oleksiiovych [UA/UA]; (UA)
Inventors: TOLCHEYEV, Yuriy Zakharovych; (UA).
KOZLOVSKYI, Vadym Oleksiiovych; (UA)
Agent: KUKSHINA, Tetyana A.; "KRYLOVA & PARTNERS" vul. Dmytrivska 56b, off. 1 Kiev, 01054 (UA)
Priority Data:
a 2015 10327 22.10.2015 UA
Title (EN) ANTIVIRAL PHARMACEUTICAL COMPOSITION
(FR) COMPOSITION PHARMACEUTIQUE ANTIVIRALE
Abstract: front page image
(EN)The invention relates to a pharmaceutical industry and particularly deals with antiviral pharmaceutical compositions. The claimed antiviral pharmaceutical composition comprises beta- glucan preferably as carboxymethyl beta-glucan of sodium salt and iota- carrageenan in the weight ratio from approximately 1-0.5 to approximately 1-5. The antiviral pharmaceutical composition can be used in a spray form to be delivered by a dosing inhaler for nasal or vaginal spray or in the form of powder for insufflation in the interior of the human body or in the form of gel.
(FR)L'invention concerne l'industrie pharmaceutique et en particulier concerne des compositions pharmaceutiques antivirales. La composition pharmaceutique antivirale de l'invention comprend un bêta-glucane, de préférence sous la forme d'un sel de sodium carboxyméthyl bêta-glucane et de carraghénane iota dans un rapport en poids compris entre environ 1 pour 0,5 et environ 1 pour 5. La composition pharmaceutique antivirale peut être utilisée sous la forme d'un spray destiné à être administré via un inhalateur calibré utilisable pour une pulvérisation nasale ou vaginale, ou sous la forme d'une poudre destinée à une administration par insufflation à l'intérieur du corps humain, ou sous la forme d'un gel.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)